Ginsenoside‐induced relaxation of human bronchial smooth muscle via release of nitric oxide

Article date: August 2000

By: J Tamaoki, J Nakata, K Kawatani, E Tagaya, A Nagai in Volume 130, Issue 8, pages 1859-1864

Ginsenoside, an extract of Panax ginseng, is an essential constituent of anti‐asthmatic Chinese herbal medicine. To elucidate whether ginsenoside affects airway smooth muscle tone and, if so, what the mechanism of action is, we studied relaxant responses of human bronchial strips under isometric condition in vitro, and directly measured the release of nitric oxide (NO) by an amperometric sensor for this molecule.

Addition of ginsenoside relaxed the tissues precontracted with acetylcholine in a dose‐dependent manner, the maximal relaxation and the ginsenoside concentration required to produce 50% relaxation being 67±8% and 210±29 μg ml−1, respectively.

The relaxant responses to ginsenoside were inhibited by NG‐nitro‐L‐arginine methylester (L‐NAME) and removal of the epithelium, but not by NG‐nitro‐D‐arginine methylester (D‐NAME) or tetrodotoxin. This inhibitory effect of L‐NAME was reversed by L‐arginine but not by D‐arginine.

Addition of ginsenoside to the medium containing bronchial tissues dose‐dependently increased NO‐selective electrical current, and this effect was greatly attenuated by the epithelial removal or Ca2+‐free medium.

Ginsenoside also increased tissue cyclic GMP contents, an effect that was abolished in the presence of L‐NAME.

It is concluded that ginsenoside induces relaxation of human bronchial smooth muscle via stimulation of NO generation predominantly from airway epithelium and cyclic GMP synthesis. This action might account for the anti‐asthmatic effect of Panax ginseng.

Ginsenoside, an extract of Panax ginseng, is an essential constituent of anti‐asthmatic Chinese herbal medicine. To elucidate whether ginsenoside affects airway smooth muscle tone and, if so, what the mechanism of action is, we studied relaxant responses of human bronchial strips under isometric condition in vitro, and directly measured the release of nitric oxide (NO) by an amperometric sensor for this molecule.

Addition of ginsenoside relaxed the tissues precontracted with acetylcholine in a dose‐dependent manner, the maximal relaxation and the ginsenoside concentration required to produce 50% relaxation being 67±8% and 210±29 μg ml−1, respectively.

The relaxant responses to ginsenoside were inhibited by NG‐nitro‐L‐arginine methylester (L‐NAME) and removal of the epithelium, but not by NG‐nitro‐D‐arginine methylester (D‐NAME) or tetrodotoxin. This inhibitory effect of L‐NAME was reversed by L‐arginine but not by D‐arginine.

Addition of ginsenoside to the medium containing bronchial tissues dose‐dependently increased NO‐selective electrical current, and this effect was greatly attenuated by the epithelial removal or Ca2+‐free medium.

Ginsenoside also increased tissue cyclic GMP contents, an effect that was abolished in the presence of L‐NAME.

It is concluded that ginsenoside induces relaxation of human bronchial smooth muscle via stimulation of NO generation predominantly from airway epithelium and cyclic GMP synthesis. This action might account for the anti‐asthmatic effect of Panax ginseng.

British Journal of Pharmacology (2000) 130, 1859–1864; doi:10.1038/sj.bjp.0703511

DOI: 10.1038/sj.bjp.0703511

View this article